Data challenge_Neonatal sepsis at Kawempe Hospital Uganda

Neonatal mortality is a significant challenge in sub-Saharan Africa, particularly in Uganda, where infections contribute substantially to high mortality rates. At Kawempe National Referral Hospital in Kampala, the management of neonatal sepsis is complicated by limited resources, resulting in infrequent blood cultures and a lack of local antimicrobial resistance (AMR) data. This project aims to leverage the AMR Vivli data to address these gaps by identifying the most common microorganisms affecting neonates at the hospital and analyzing their resistance and susceptibility patterns. Our research will directly impact patient outcomes by providing clinicians with critical information on the pathogens responsible for neonatal sepsis and their resistance profiles. This data-driven approach will enable more accurate and effective treatment decisions, potentially reducing mortality and morbidity rates among newborns. Additionally, understanding local AMR patterns will help in developing targeted interventions and antibiotic stewardship programs, ensuring that antibiotics are used judiciously and effectively, thus preserving their efficacy. By identifying prevalent pathogens and their resistance trends, our study will also inform public health practices. The insights gained can be used to design and implement better infection control measures and surveillance systems, not only within the hospital but also at a regional and national level. This will enhance the overall capacity to monitor and respond to AMR threats, contributing to stronger health systems. Ultimately, our research aims to bridge the data gap in neonatal AMR surveillance in Uganda, providing a foundation for improved clinical practice, better patient outcomes, and enhanced public health strategies. The findings will be disseminated to key stakeholders, including healthcare providers, policymakers, and public health officials, ensuring that the knowledge gained is translated into actionable strategies to combat AMR and improve neonatal health in Uganda and global heath at large.